1 谢幸,苟文丽,妇产科学.第八版.人民卫生出版社,2014:354. 2 曹泽毅.中华妇产科学.第2版.北京:人民卫生出版社,2004:2565-2568. 3 Laml T,Schlz-Lobmeyr I,Obruca A,et al.Premature ovarian failure:etiology and prospects.Gynecol Endocrinol,2000,14:292-302. 4 Kalantaridou SN,Davis SR,Nelson LM.Premature ovaria failure .Endocrinol Metab Clin North Am,1998,27:989-1006. 5 Baggiolini M,Dewald B,Moser B.Human chemokines:an update.Annu Rev Immunol,1997,15:675-705. 6 Miller WL.Androgen biosynthesis from cholesterol to DHEA.Mol cell Endocrinol,2002,198:7-14. 7 Maclaran K,Panay N.Current concepts in premature ovarian insufficiency.Womens Health(Lond),2015,11:169-182. 8 Ferraretti AP,La Marca A,Fauser BC,et al.ESHRE Working Group on Poor Ovarian Response Definition.ESHRE consensus on the definition of ‘poor response’to ovarian stimulation for in vitro fertilization:the Bologna criteria.Hum Reprod,2011,26:1616-1624. 9 Ferraretti AP,Gianaroli L.The Bologna criteria for the definition of poor ovarian responders:is there a need for revision?Hum Reprod,2014,29:1842-1845. 10 Kovanci E,Schutt AK.Premature ovarian failure:clinical presentation and treatment.Obstet Gynecol Clin North Am,2015,42:153-161.